LifeSignals Wireless Medical Biosensor LP1250 Receives FDA Clearance


LifeSignals Wireless Medical Biosensor LP1250 receives FDA clearance World’s first single-use two channel ECG and heart rate biosensor provides 72- hour patient monitoring with remote data access in ambulatory, hospital and home settings

FREMONT, Calif.- LifeSignals Group, today announced USFDA 510(k) clearance has been received for their LifeSignals ECG Remote Monitoring Biosensor Platform. The LifeSignals ECG Remote Monitoring Biosensor Platform is a wireless remote monitoring system intended for use by healthcare professionals for the continuous collection of Electrocardiography (ECG) and Heart Rate monitoring in the ambulatory, hospital, home, and healthcare settings. Data is transmitted wirelessly from the LifeSignals Wireless Medical Biosensor LP1250 to a remote Secure Server for storage and analysis.

Healthcare professionals can remotely access patient data via third-party software for the screening and monitoring of common Cardiac Arrhythmias such as Atrial Fibrillation, enabling rapid treatment decisions, independent of patient location.

“This FDA clearance represents a major step forward in our drive to “untether” patient monitoring systems,” said Surendar Magar, co-founder, and CEO of LifeSignals. “The interoperable Biosensor gives partners access to a ready-to-integrate, multi-parameter medical wearable with a straightforward ecosystem for fast onboarding. Once in use, it enables remote patient monitoring services to be expanded rapidly and professionals can make faster treatment decisions while patients can be confident of receiving data-driven, personalized therapy”

The LifeSignals Wireless Medical Biosensor LP1250 has several unique features:
72-hour data capture of two-channel ECG and Heart Rate data for enhanced patient diagnosis

Single-use device that reduces infection control concerns and operational costs

Lightweight and splash-proof for improved patient comfort and compliance

Proprietary patented single-chip LC1100 LifeSignals Processor platform, allowing secure detection, storage, and transmission of patient data even in ‘noisy’ multi-patient hospital environments

FDA clearance follows CE marking and HSA approval. The LifeSignals Wireless Medical Biosensor LP1250 will be sold worldwide as a white-labeled device through a network of partnerships from OEMs and telehealth software providers to specialist hospital facilities.

About LifeSignals, Inc.
LifeSignals (formerly HMicro Inc.) is the Silicon Valley-based creator and producer of the patented LifeSignals Processor, a semiconductor platform designed to faithfully capture and communicate vital life signals from humans and animals to the cloud. LifeSignals is a venture capital-backed, a fabless semiconductor company, enabled by equity investments from Flex, Uniquest, Dreamtech, Renew Group, Seraph Capital, Xseed Capital, and Reddy Capital. Further information can be found at


Kim Ramessa
Marketing and Communications Director
LifeSignals Group
M: +44 (0) 7425 316305


Richard Hayhurst
M: +44 (0) 7711 821527